Overview

RTA 744 in Breast Cancer Patients With Progression of Previously Irradiated Brain Metastases

Status:
Terminated

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether RTA 744 is effective in the treatment of breast cancer that has metastasized to the brain.

Phase:

Phase 2

Details

Lead Sponsor:

Reata Pharmaceuticals, Inc.